HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Bicyclol

HCID 9821754
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
118159-48-1
Standard SMILES
COC(=O)c1cc(OC)c2c(c1-c1c(CO)cc(OC)c3c1OCO3)OCO2
InChIKey
KXMTXZACPVCDMH-UHFFFAOYSA-N
Molecular formula
C19H18O9
Average molar mass
390.3 g/mol
Monoisotopic mass
390.09508215

Overview

Bicyclol is under investigation in clinical trial NCT02944552 (The Multi Center, Randomized, Double-blind, Positive Controlled Study of Bicyclol in the Treatment of Acute DILI).

Names & identifiers

Preferred name
Bicyclol
IUPAC
methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate
English name
Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate
Molecular formula
C19H18O9
Molecular weight
390.34

Names & synonyms

bicyclol118159-48-14,4'-Bi-1,3-benzodioxole)-5-carboxylic acid, 5'-(hydroxymethyl)-7,7'-dimethoxy-, methyl estermethyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate9734122TH2DTXSID301520264,4'-bi-(1,3-benzodioxole)-5-carboxylic acid, 5'-(hydroxymethyl)-7,7'-dimethoxy-, methyl estermethyl 4-(5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl)-7-methoxy-1,3-benzodioxole-5-carboxylateRefChem:119748DTXCID9074517633-021-4Methyl 5'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5-carboxylate
Show more names
CS-1347Bicyclol, SY 801Bicyclol USP/EP/BPBifendate Impurity 17Bicyclol, 10 mM in DMSOBifendate Impurity 6 (Bicyclol)Bicyclol,SY 801,SY-801,Inhibitor,Hepatitis B virus,Autophagy,inhibit,HBV
Bicyclol [WHO-DD]SY801HY-B0766s64535'-(hydroxymethyl)-7,7'-dimethoxy-[4,4'-bi-1,3-benzodioxole]-5-carboxylic acid, methyl esterAKOS016007877Q27271958UNII-9734122TH2

Properties

Computed structural properties

XLogP
2.1
Topological polar surface area
102 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
9
Rotatable bonds
6
Heavy atoms
28
Formal charge
0
Complexity
558

Experimental & physicochemical properties

LogP1.7

Physicochemical properties

Boiling point
608.1 · 608.1±55.0 °C(Predicted)
Density
1.41 · 1.410±0.06 g/cm3(Predicted)
storage temp.
2 · Inert atmosphere,2-8°C
solubility
10 mg/mL · DMSO: >10mg/mL
form
powder
pka
13.85 · 13.85±0.10(Predicted)
color
white to off-white
InChI
InChI=1S/C19H18O9/c1-22-11-4-9(6-20)13(17-15(11)25-7-27-17)14-10(19(21)24-3)5-12(23-2)16-18(14)28-8-26-16/h4-5,20H,6-8H2,1-3H3
InChIKey
KXMTXZACPVCDMH-UHFFFAOYSA-N
SMILES
O1C2=C(OC)C=C(C(OC)=O)C(C3=C4C(=C(OC)C=C3CO)OCO4)=C2OC1
FDA UNII
9734122 TH2 · 9734122TH2
Comptox DTXSID
30152026 · DTXSID30152026

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H400 (100%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard]

P273, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesAquatic Acute 1 (100%)

Safety data

rtecs
DT4312000
ridadr
UN 3077 9 / PGIII
risk_code
50/53
Signal word
Warning
Symbol(GHS)
GHS09
hazard_code
N
safety_code
60-61
Hazard statements
H400
Precautionary statements
P273

Chemistry & industry

Applications · 2 items

DescriptionBicyclol is a hepatoprotective agent. It has antiviral activity against hepatitis B (HBV), reducing viral DNA and the secretion of the HBV antigens HBsAg and HBeAg by 59 and 35%, respectively, in infected 2.2.15 HepG2 cells. In vivo, bicyclol reduces duck HBV (DHBV) DNA in DHBV-infected ducks at doses ≥0.4 g/kg. It also reduces the expression of TNF-α and the accumulation of lymphocytes in the liver in a mouse model of liver injury induced by concanavalin A . Oral administration of bicyclol prior to injection of diethylnitrosamine (DEN) and phenobarbital (PB; Item Nos. 9001494 | 20987) prevents formation of DEN/PB-induced hepatocellular carcinomas. It also reduces liver fibrosis in a rat model of bile duct ligation-induced hepatic fibrosis.

UsesBicyclol is a novel hepatoprotectant shown to protect against liver injury by inducing Hsps, including Hsp27 and Hsp 70; Anti-inflammatory activity.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
118159-48-1
PubChem CID
9821754
DTXSID
DTXSID30152026
ChEMBL
CHEMBL482035
UNII
9734122TH2
EC Number
633-021-4
Nikkaji
J2.598.891D
Symbol(GHS)
9 · GHS09
Signal word
Warning
Hazard statements
400 · H400
Precautionary statements
273 · P273
Hazard Codes
N
Risk Statements
50 · 50/53
Safety Statements
60 · 60-61
RIDADR
3077 · UN 3077 9 / PGIII
RTECS
4312000 · DT4312000